Safety and Efficacy of Sorafenib for the Treatment of Recurrent Hepatocellular Carcinoma after Liver Transplantation

被引：0
|
作者：
Waghray, Abhijeet [1 ]
Balci, Bengi [1 ]
El-Gazzaz, Galal [1 ]
Miller, Charles M. [1 ]
Pelley, Robert J. [1 ]
Aucejo, Federico N. [1 ]
Menon, K. V. Narayanan [2 ]
机构：
[1] Cleveland Clin Fdn, Cleveland, OH 44195 USA
[2] Cleveland Clin, Cleveland, OH 44106 USA
来源：
HEPATOLOGY | 2012年 / 56卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
559
引用
收藏
页码：463A / 464A
页数：2
相关论文
共 50 条
  • [41] Analysis of Clinical Efficacy of Sorafenib on Patients with Hepatocellular Carcinoma after Liver Transplantation.
    Zhou, Jian
    Dou, Qiujiang
    Liao, Yuan
    Guo, Zhiyong
    He, Xiaoshun
    LIVER TRANSPLANTATION, 2013, 19 : S161 - S161
  • [42] Efficacy and Safety of Sorafenib in the Prevention and Treatment of HCC Recurrences after Liver Transplantation
    Hu, Anbin
    Tai, Qiang
    He, Xiaoshun
    LIVER TRANSPLANTATION, 2013, 19 : S216 - S216
  • [43] Can Sorafenib Increase Survival for Recurrent Hepatocellular Carcinoma after Liver Transplantation? A Pilot Study
    Alsina, Angel E.
    Makris, Alexia
    Nenos, Vasilios
    Sucre, Eduardo
    Arrobas, Jade
    Franco, Edson
    Kemmer, Nyingi
    AMERICAN SURGEON, 2014, 80 (07) : 680 - 689
  • [44] Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments
    Tovoli, Francesco
    Pallotta, Dante Pio
    Sansone, Vito
    Iavarone, Massimo
    De Giorgio, Massimo
    Ielasi, Luca
    Di Costanzo, Giovan Giuseppe
    Giuffrida, Paolo
    Sacco, Rodolfo
    Pressiani, Tiziana
    Di Donato, Maria Francesca
    Trevisani, Franco
    Fagiuoli, Stefano
    Piscaglia, Fabio
    Granito, Alessandro
    TRANSPLANTATION, 2023, 107 (01) : 156 - 161
  • [45] EVEROLIMUS AND SORAFENIB FOR RECURRENCE OF HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION
    De Simone, Paolo
    Pezzati, Daniele
    Lai, Quirino
    Ghinolfi, Davide
    Coletti, Laura
    Precisi, Arianna
    Leonardi, Giulia
    Carrai, Paola
    Filipponi, Franco
    TRANSPLANT INTERNATIONAL, 2013, 26 : 293 - 293
  • [46] Sorafenib in hepatocellular carcinoma (HCC) patients after liver transplantation
    Feun, L. G.
    Levi, D.
    Moon, J.
    Nishida, S.
    Island, E.
    Selvaggi, G.
    Martin, P.
    Savaraj, N.
    Mendes, F.
    Tzakis, A.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [47] EVEROLIMUS PLUS SORAFENIB AS A TREATMENT OPTION FOR HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
    Saliba, F.
    Younes, A.
    Nitta, H.
    Karam, V.
    Sobesky, R.
    Vibert, E.
    Coilly, A.
    Antonini, T.
    Cherqui, D.
    Baba, H.
    Adam, R.
    Samuel, D.
    TRANSPLANT INTERNATIONAL, 2019, 32 : 17 - 17
  • [48] Everolimus plus Sorafenib as a treatment option for hepatocellular carcinoma recurrence after liver transplantation
    Saliba, Faouzi
    Nitta, Hidetoshi
    Younes, Aline
    Karam, Vincent H.
    Sobesky, Rodolphe
    Vibert, Eric
    Coilly, Audrey
    Antonini, Theresa
    Cherqui, Daniel
    Adam, Rene
    Samuel, Didier
    HEPATOLOGY, 2017, 66 : 901A - 902A
  • [49] Regorafenib improves survival after sorafenib treatment in patients with recurrent hepatocellular carcinoma after liver transplantation, compared to best supportive care
    Iavarone, Massimo
    Invernizzi, Federica
    Zavaglia, Claudio
    Sanduzzi Zamparelli, Marco
    Fraile, Miguel
    Czauderna, Carolin
    Di Costanzo, Giuseppe
    Bhoori, Sherrie
    Pinter, Matthias
    Manini, Matteo Angelo
    Amaddeo, Giuliana
    Fernandez, Ainhoa
    Pinero, Federico
    Blanco Rodriguez, Maria Jose
    Anders, Maria Margarita
    Aballay Soteras, Gabriel Alejandro
    Villadsen, Gerda Elisabeth
    Cesarini, Lucia
    Mazza, Stefano
    Diaz-Gonzalez, Alvaro
    Gonzalez Dieguez, Maria Luisa
    Tortora, Raffaella
    Weinmann, Arndt
    Mazzaferro, Vincenzo
    Romero, Mario
    Crespo, Gonzalo
    Regnault, Helene
    De Giorgio, Massimo
    Varela, Maria
    Donato, Maria Francesca
    Worns, Marcus-Alexander
    Bruix, Jordi
    Lampertico, Pietro
    Reig, Maria
    JOURNAL OF HEPATOLOGY, 2020, 73 : S103 - S104
  • [50] TOLERABILITY OF SORAFENIB IN RECURRENT HEPATOCELLULAR CARCINOMA AFTER LIVER TRANSPLANTATION: A CASE-CONTROL STUDY.
    Dharancy, S.
    Romano, O.
    Lohro, R.
    Pageaux, G. P.
    De Ledinghen, V.
    Hurtova, M.
    Vanlemmens, C.
    Salame, E.
    Cattan, S.
    Boleslamski, E.
    Mathurin, R.
    Pruvot, F. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S216 - S216
12345